Cargando…

The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19

The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, while no treatment has been proven effective. COVID-19 pathophysiology involves the activation of three main pathways: the inflammatory, the coagulation and the bradykinin cascades. Here, we highlight for the first time the joint pot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kritis, Panagiotis, Karampela, Irene, Kokoris, Styliani, Dalamaga, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	COVID-19 in Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661945/ https://www.ncbi.nlm.nih.gov/pubmed/33205039 http://dx.doi.org/10.1016/j.metop.2020.100066

Ejemplares similares

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
por: Dalamaga, Maria, et al.
Publicado: (2020)

SARS-CoV-2 adipose tissue infection and hyperglycemia: A further step towards the understanding of severe COVID-19
por: Tsilingiris, Dimitrios, et al.
Publicado: (2022)

Visceral fat is associated to the severity of COVID-19
por: Favre, Guillaume, et al.
Publicado: (2021)

Excess body weight is an independent risk factor for severe forms of COVID-19
por: Pietri, Léa, et al.
Publicado: (2021)

Association of obesity and its genetic predisposition with the risk of severe COVID-19: Analysis of population-based cohort data
por: Zhu, Zhaozhong, et al.
Publicado: (2020)

Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study
por: Freuer, Dennis, et al.
Publicado: (2021)

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020)

Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19
por: Zimilover, Adam, et al.
Publicado: (2022)

Boosting telemedicine through remote monitoring of cardiac electronic devices during the Italian COVID-19 outbreak
por: Mugnai, Giacomo, et al.
Publicado: (2021)

Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19
por: Papi, Alberto, et al.
Publicado: (2023)

Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
por: Bozzi, Giorgio, et al.
Publicado: (2021)

Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives
por: Dalamaga, Maria, et al.
Publicado: (2021)

Preexisting comorbidities shape the immune response associated with severe COVID-19
por: Kreutmair, Stefanie, et al.
Publicado: (2022)

Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19
por: Abolhassani, Hassan, et al.
Publicado: (2022)

Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event?
por: Vallianou, Natalia G., et al.
Publicado: (2022)

Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

Obesity in patients with COVID-19: a systematic review and meta-analysis
por: Huang, Yi, et al.
Publicado: (2020)

Metabolic impact of weight loss induced reduction of adipose ACE-2 – Potential implication in COVID-19 infections?
por: Li, Linna, et al.
Publicado: (2020)

Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: Population-based, prospective cohort study
por: Hamer, Mark, et al.
Publicado: (2020)

Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19
por: Watanabe, Mikiko, et al.
Publicado: (2020)

Commentary. Eliminating vitamin D deficiency during the COVID-19 pandemic: A call to action
por: Manson, JoAnn E., et al.
Publicado: (2020)

Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()()
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone
por: Ganjali, Shiva, et al.
Publicado: (2020)

The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study()
por: Ghoneim, Sara, et al.
Publicado: (2020)

Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis
por: Du, Yanbin, et al.
Publicado: (2021)

Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemic
por: Chakhtoura, M., et al.
Publicado: (2020)

The serum metabolome of COVID-19 patients is distinctive and predictive
por: Shi, Ding, et al.
Publicado: (2021)

COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic
por: Tessier, Christopher M., et al.
Publicado: (2021)

SARS-CoV-2 and diabetes: A potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Systematic review with meta-analysis of diagnostic test accuracy for COVID-19 by mass spectrometry
por: Spick, Matt, et al.
Publicado: (2022)

Drug repurposing in COVID-19: A review with past, present and future
por: Srivastava, Kamna, et al.
Publicado: (2021)

Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19
por: Calvisi, Stefania L., et al.
Publicado: (2021)

A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Diabetic ketoacidosis in pediatric patients with type 1- and type 2 diabetes during the COVID-19 pandemic()
por: Loh, Charlotte, et al.
Publicado: (2021)

Awareness of and practice toward cancer prevention recommendations: results of the Korean National Cancer Prevention Awareness and Practice Survey in 2021
por: Oh, Jin-Kyoung, et al.
Publicado: (2022)

Preventing Frailty Progression During the Covid-19 Pandemic
por: Boreskie, Kevin F., et al.
Publicado: (2020)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Burden and prevalence of prognostic factors for severe COVID-19 in Sweden
por: Gémes, Katalin, et al.
Publicado: (2020)

Clinical and neurophysiological characterization of muscular weakness in severe COVID-19
por: Bax, Francesco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e4m1kt7dtatsd7aa2r1g3g5jbi